We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Strategic Partnership Advances Wearable Medical Devices

By HospiMedica International staff writers
Posted on 17 Nov 2014
Welch Allyn (Skaneateles Falls, NY, USA), a leading medical diagnostic device company, and Gentag (Washington DC, USA), a pioneer in disposable biosensors, have announced a strategic development agreement.

Under the terms of the agreement, Welch Allyn and Gentag will collaborate to bring to market near field communication (NFC) devices that will be integrated into medical devices and sensors. More...
The short-range wireless communication uses an antenna that is much smaller than the wavelength of the carrier signal. As a result, NFC communicates either by a modulated electric field, or a modulated magnetic field, but not by radio electromagnetic waves. For example, a small loop antenna produces a magnetic field, which can then be picked up by another small loop antenna, if it is near enough.

The partnership will enable Welch Allyn to offer solutions for remote patient monitoring worldwide by combining Gentag's NFC technology and integrated, ultrathin, battery-less wireless sensors into various medical diagnostic devices and applications. The collaboration is expected to create a range of significant opportunities for workflow efficiency gains and faster availability of clinical information in the Electronic Health Record (EHR).

“This collaborative opportunity will enable Welch Allyn to provide clinicians with smart monitoring solutions and improve patient access to cutting edge diagnostics,” said Stephen Meyer, president and CEO of Welch Allyn.

“Welch Allyn has the knowledge, expertise, and global market reach that will allow the globalization of NFC technologies in medical diagnostic settings,” said John Peeters, CEO of Gentag. “By combining our intellectual property and technology portfolios with Welch Allyn, we feel that patients will be better served by the worldwide availability of high quality wireless medical devices.”

The use of wearable remote patient monitoring (RPM) biosensors that allow constant monitoring of physiological signals is becoming essential for the advancement of both the diagnosis and treatment of diseases. RPM systems allow physicians to overcome the limitations of technology and provide a response to the need for monitoring individuals over weeks or months. The data sets recorded using these systems are then processed to detect events predictive of possible worsening of the patient’s clinical situations, as well as assess the impact of clinical interventions.

Related Links:

Welch Allyn
Gentag



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Surgical Techniques

view channel
Image Credit: 123RF

Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.